Asian Journal of Neurosurgery

: 2019  |  Volume : 14  |  Issue : 3  |  Page : 641--647

Delayed ischemic neurologic deficit after aneurysmal subarachnoid hemorrhage

Vitor Nagai Yamaki1, Daniel Dutra Cavalcanti2, Eberval Gadelha Figueiredo1 
1 Department of Neurosurgery, Universidade De Sao Paulo, São Paulo, SP, Brazil
2 Department of Neurosurgery, Barrow Neurological Institute, Phoenix, AZ, USA

Correspondence Address:
Vitor Nagai Yamaki
Rua Arruda Alvim, 49 – Apt153, Zip Code: 054100-20, São Paulo, SP

Delayed ischemic neurologic deficit (DIND) is the main preventable cause of poor outcomes in aneurysmal subarachnoid hemorrhage (SAH) patients. Of 50% of survivors from a SAH, approximately 30% of patients will present clinical vasospasm (VS). The cornerstone of the DIND management comprises prevention and early identification. Several diagnostic methods have been proposed differing in efficacy, invasiveness, and costs. Serial neurological examination is the most reliable method to detect a new neurological deficit. On the other hand, comatose patients require advanced monitoring methods which identify changes in the microcirculatory environment, brain autoregulation, and spreading depolarization. Multimodality monitoring with continuous electroencephalography, microdialysis, and intracranial pressure monitoring represents altogether the current state-of-art technology for the intensive care of SAH patients. Moreover, advances in genetic biomarkers to predict clinical VS have shown consistent accuracy which may in the near future allow the early prediction of DIND through a simple blood test. Several clinical trials have tested drugs with theoretical effects on DIND prevention or treatment. Nevertheless, nimodipine remains the Holy Grail in the prevention of clinical VS. Among rescue therapies, the endovascular treatment through intra-arterial vasodilator (verapamil or nicardipine) infusion is the most employed method for DIND reversal; however, there is no good quality evidence comparing results of intra-arterial infusion of vasodilators versus balloon angioplasty. Although we have addressed the most refined technology in the management of SAH and DIND, the clinical experience and strict follow-up in neurointensive care will be determinant for favorable long-term outcomes.

How to cite this article:
Yamaki VN, Cavalcanti DD, Figueiredo EG. Delayed ischemic neurologic deficit after aneurysmal subarachnoid hemorrhage.Asian J Neurosurg 2019;14:641-647

How to cite this URL:
Yamaki VN, Cavalcanti DD, Figueiredo EG. Delayed ischemic neurologic deficit after aneurysmal subarachnoid hemorrhage. Asian J Neurosurg [serial online] 2019 [cited 2019 Nov 15 ];14:641-647
Available from:;year=2019;volume=14;issue=3;spage=641;epage=647;aulast=Yamaki;type=0